表紙:ライフサイエンス分析における人工知能(AI)の世界市場:2023-2030年
市場調査レポート
商品コード
1351029

ライフサイエンス分析における人工知能(AI)の世界市場:2023-2030年

Global Artificial Intelligence (AI) in Life Science Analytics Market 2023-2030

出版日: | 発行: Orion Market Research | ページ情報: 英文 155 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
ライフサイエンス分析における人工知能(AI)の世界市場:2023-2030年
出版日: 2023年09月08日
発行: Orion Market Research
ページ情報: 英文 155 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のライフサイエンス分析におけるAI市場は、予測期間中(2023-2030年)にCAGR 9.7%で成長すると予測されています。ヘルスケア産業におけるAlの採用が増加していることが、ライフサイエンス分析におけるAl市場の成長を促進すると予想されます。機械学習(ML)やディープラーニング(深層学習)プロセスなどの技術が含まれ、AIとともに頻繁に言及されます。創薬、臨床試験、医療診断、患者モニタリング、個別化医療などのライフサイエンス分析は、AIやその他の技術を幅広く活用する主要分野です。International Business Machines Corp.によると、2022年3月には世界企業の35%が世界中でAlを使用しており、42%の企業が自社のプロセスやアプリケーションにAlを組み込むことを前向きに検討しています。したがって、市場プレーヤーはAIベースのソリューションの導入にも注力しており、これが市場の成長をさらに後押しすることになります。例えば、2023年5月、コグニザントは、コグニザント・ニューロ(R)AIを発表しました。コグニザント・ニューロ(R)AIは、生成的なAI技術の採用を迅速化し、その経済的価値を、柔軟で、安全で、拡張可能で、責任ある方法で活用するための包括的な方法を企業に提供するために作成された、企業全体の新しいプラットフォームです。

セグメント別の展望

ライフサイエンス分析におけるAIの世界市場では、研究センターがかなりのシェアを占めると予測されます。

エンドユーザーの中では、研究センターのサブセグメントが市場のかなりのシェアを占めると予測されています。市場の成長を支える要因としては、臨床試験におけるAIの利用の高まりが挙げられます。臨床試験は、定期的に膨大な量のデータを生成するため、ライフサイエンス業界で最もデータ集約的な作業の1つです。このため、多くの製薬会社や臨床研究機関が人工知能のような技術に投資するようになっています。現在の市場シナリオでは、AIの急速な導入は製薬セクターで広く見られ、世界で実施される臨床試験のほぼ50%を毎年担っています。さらに、世界の臨床試験の増加により、パブリックドメインで利用可能な膨大な量のデータが生成されます。予測期間中、これらの数は少なくとも11%増加すると予想され、特に欧州と北米で臨床試験アプリケーションにおけるAIの新たな機会が創出されます。

地域別展望

ライフサイエンス分析におけるAIの世界市場は、北米(米国、カナダ)、欧州(英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域)、アジア太平洋地域(インド、中国、日本、韓国、その他アジア地域)、世界のその他の地域(中東とアフリカ、中南米)を含む地域に基づいてさらに区分されます。このうち、アジア太平洋地域は、製品ラインの機能を強化するためにAIベースのライフサイエンス・ソリューションを開発する新興企業の買収が増加していることから、世界市場で突出したシェアを占めると予想されます。

ライフサイエンス分析におけるAI世界市場において北米地域が大幅なCAGRで成長する見込み

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。AI技術に対する需要の増加、デジタルリテラシーのレベル向上、ライフサイエンス分析における改善はすべて、この地域の成長に寄与する要因として示唆されています。さらに、様々な政府イニシアチブの導入や、民間部門と公的部門とのパートナーシップも大幅に増加しています。これらの戦略は、技術的ソリューションを開発するために採用されており、ひいては市場成長の原動力となっています。例えば、Databricks社は2022年3月、ヘルスケアおよびライフサイエンス業界の組織向けに業界初のレイクハウス・プラットフォームを発表しました。DatabricksのLakehouse for Healthcare and Life Sciencesは、業界の一般的な課題に対処するため、顧客に合わせたデータとAIソリューションを提供します。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Amazon Web Services, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Databricks, Inc.
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Indegene
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • ライフサイエンス分析におけるAIの世界市場:デプロイメント別
    • オンプレミス
    • クラウド
  • ライフサイエンス分析におけるAIの世界市場:用途別
    • 製薬
    • バイオテクノロジー
    • 医療機器
    • その他(個別化医療、医療診断)
  • ライフサイエンス分析におけるAIの世界市場:エンドユーザー別
    • 製薬・バイオテクノロジー企業
    • 医療機器企業
    • 研究センター

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Accenture plc
  • Allscripts Healthcare
  • Alteryx, Inc.
  • Axtria
  • CitiusTech Inc.
  • Clarivate
  • Cognizant
  • IBM
  • Inovalon
  • Lexalytics, Inc.
  • MaxisIT
  • Microsoft Corp.
  • Optum, Inc.
  • Oracle
  • Saama Technologies, LLC
  • Sisense
  • Sorcero
  • ThoughtSpot Inc.
  • Veeva Systems Inc.
図表

LIST OF TABLES

  • 1. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
  • 2. GLOBAL ON-PREMISE BASED AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL CLOUD-BASED AI IN LIFE SCIENCE ANALYTICS SOLUTION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 5. GLOBAL AI IN LIFE SCIENCE ANALYTICS FOR PHARMACEUTICAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL AI IN LIFE SCIENCE ANALYTICS FOR BIOTECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL AI IN LIFE SCIENCE ANALYTICS FOR MEDICAL DEVICE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL AI IN LIFE SCIENCE ANALYTICS FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 10. GLOBAL AI IN LIFE SCIENCE ANALYTICS IN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL AI IN LIFE SCIENCE ANALYTICS IN MEDICAL DEVICE COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL AI IN LIFE SCIENCE ANALYTICS IN RESEARCH CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 18. EUROPEAN AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. EUROPEAN AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
  • 20. EUROPEAN AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 21. EUROPEAN AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 22. ASIA- PACIFIC AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. ASIA- PACIFIC AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
  • 24. ASIA- PACIFIC AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022 VS 2030 (%)
  • 2. GLOBAL ON-PREMISE BASED AI AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL CLOUD-BASED AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022 VS 2030 (%)
  • 5. GLOBAL AI IN LIFE SCIENCE ANALYTICS FOR PHARMACEUTICAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL AI IN LIFE SCIENCE ANALYTICS FOR BIOTECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL AI IN LIFE SCIENCE ANALYTICS FOR MEDICAL DEVICE MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL AI IN LIFE SCIENCE ANALYTICS FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022 VS 2030 (%)
  • 10. GLOBAL AI IN LIFE SCIENCE ANALYTICS IN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL AI IN LIFE SCIENCE ANALYTICS IN MEDICAL DEVICE COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL AI IN LIFE SCIENCE ANALYTICS IN RESEARCH CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. US AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. CANADA AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. UK AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. FRANCE AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. GERMANY AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ITALY AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SPAIN AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF EUROPE AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. INDIA AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CHINA AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. JAPAN AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SOUTH KOREA AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027630

Title: Global Artificial Intelligence (AI) in Life Science Analytics Market Size, Share & Trends Analysis Report by Deployment (On-Premise, and Cloud), by Application (Pharmaceutical, Biotechnology, Medical Device, and Others), and by End-Users (Pharmaceutical and Biotechnology Companies, Medical Device Companies, and Research Centers),Forecast Period (2023-2030).

The global AI in life science analytics market is anticipated to grow at a CAGR of 9.7% during the forecast period (2023-2030). The increasing adoption of Al in healthcare industry is expected to propel the growth of Al in the life science analytics market. It involves technologies such as machine learning (ML) and deep learning processes, which are frequently mentioned along with AI. Life science analytics, such as drug discovery, clinical trials, medical diagnosis, patient monitoring, and personalized medicine are the key fields utilizing AI and other technologies extensively. According to International Business Machines Corp., in March 2022, 35% of global companies are using Al across the globe, and 42% of companies are looking forward to embedding Al in their processes and applications. Hence, the market players are also focusing on introducing AI-based solutions which will further bolster the market growth. For instance, in May 2023, Cognizant announced Cognizant Neuro® AI is a new, enterprise-wide platform created to give businesses a holistic method to quicken the adoption of generative AI technology and capitalize on its economic value in a flexible, secure, scalable, and responsible manner.

Segmental Outlook

The global AI in life science analytics market is segmented on the deployment, application, and end-users. Based on the deployment, the market is sub-segmented into on-premise and cloud. Based on the application, the market is sub-segmented into pharmaceutical, biotechnology, medical device and other (personalized medicine and medical diagnosis). Further, on the basis of end-users, the market is sub-segmented into pharmaceutical and biotechnology companies, medical device companies, and research centers. Among the end-users, the medical device company sub-segment is anticipated to hold a considerable share of the market owing to the growth in AI-based medical device development for data management, remote surgery, diagnostic and procedural assistance, clinical trials, and more.

Research Centers Sub-Segment is Anticipated to Hold a Considerable Share of the Global AI in Life Science Analytics Market

Among the end-users, research centers sub-segment is anticipated to hold a considerable share of the market. The factor supporting the market growth includes the rising use of AI in clinical trials. Clinical trials are one of the most data intensive tasks in life science industry, as it generates a huge amount of data regularly. This encourages many pharmaceutical companies and clinical research organizations to invest in technologies like artificial intelligence. In the current market scenario, the rapid adoption of AI is widely seen in the pharmaceutical sector, which is responsible for almost 50% of the clinical trials conducted globally every year. Furthermore, the increasing number of clinical trials worldwide produces colossal amounts of data available in the public domain. Over the forecast period, these numbers are expected to increase by at least 11%, creating new opportunities for AI in clinical trial applications, especially in Europe and North America.

Regional Outlook

The global AI in life science analytics market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market around the globe, owing to the rising acquisitions of start-ups developing AI-based life sciences solutions to enhance the capabilities of product line.

The North America Region is Expected to Grow at a Significant CAGR in the Global AI in Life Science Analytics Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Increased demand for AI technologies, rising levels of digital literacy, and improvements in life science analytics are all suggested as factors contributing to the region's growth. Additionally, there is a considerable increase in the introduction of various government initiatives and partnerships between the private & public sectors. These strategies are being adopted to develop technical solutions, which in turn will drive the market growth. For instance, in March 2022, Databricks launched the industry's first lakehouse platform for organizations across the healthcare and life sciences industries. Databricks' Lakehouse for Healthcare and Life Sciences offers customers tailored data and AI solutions to address common industry challenges.

Market Players Outlook

The major companies serving the AI in life science analytics market include: Accenture plc, Amazon Web Services, Inc., Databricks, Inc., Indegene, IQVIA, SAS Institute Inc. Microsoft Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2022, the Health Management Academy (The Academy) partnered forces with Nuance, a Microsoft subsidiary, to offer innovative cloud and AI technologies to the healthcare industry. The partnership aims to create a novel initiative around market forces and novel developments for AI and ML.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global AI in life science analytics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Amazon Web Services, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Databricks, Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Indegene
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global AI in Life Science Analytics Market by Deployment
    • 4.1.1. On-Premise
    • 4.1.2. Cloud
  • 4.2. Global AI in Life Science Analytics Market by Application
    • 4.2.1. Pharmaceutical
    • 4.2.2. Biotechnology
    • 4.2.3. Medical Device
    • 4.2.4. Other (Personalized Medicine and Medical Diagnosis)
  • 4.3. Global AI in Life Science Analytics Market by End-Users
    • 4.3.1. Pharmaceutical and Biotechnology Companies
    • 4.3.2. Medical Device Companies
    • 4.3.3. Research Centers

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Accenture plc
  • 6.2. Allscripts Healthcare
  • 6.3. Alteryx, Inc.
  • 6.4. Axtria
  • 6.5. CitiusTech Inc.
  • 6.6. Clarivate
  • 6.7. Cognizant
  • 6.8. IBM
  • 6.9. Inovalon
  • 6.10. Lexalytics, Inc.
  • 6.11. MaxisIT
  • 6.12. Microsoft Corp.
  • 6.13. Optum, Inc.
  • 6.14. Oracle
  • 6.15. Saama Technologies, LLC
  • 6.16. Sisense
  • 6.17. Sorcero
  • 6.18. ThoughtSpot Inc.
  • 6.19. Veeva Systems Inc.